Metastatic sarcomas to pleural effusion: a 10-year large tertiary care center experience with emphasis on clinical features and cytomorphologic characteristics
Journal of the American Society of Cytopathology · 2023
DOI: 10.1016/j.jasc.2023.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Cytopathology, 2023. Verfasst von Carla Saoud und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Sarcoma, Pleural Effusion, Pleural Effusion, Malignant, Bone Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Metastatic sarcomas to pleural effusion are extremely rare, accounting for
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: Sali@jhmi.edu.
Zitieren
APA
Saoud, C., & Ali, S. Z. (2023). Metastatic sarcomas to pleural effusion: a 10-year large tertiary care center experience with emphasis on clinical features and cytomorphologic characteristics. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2023.01.005
Vancouver
Saoud C, Ali SZ. Metastatic sarcomas to pleural effusion: a 10-year large tertiary care center experience with emphasis on clinical features and cytomorphologic characteristics. Journal of the American Society of Cytopathology. 2023. doi:10.1016/j.jasc.2023.01.005
BibTeX
@article{Saoud2023,
author = {Saoud, Carla and Ali, Syed Z},
title = {Metastatic sarcomas to pleural effusion: a 10-year large tertiary care center experience with emphasis on clinical features and cytomorphologic characteristics},
journal = {Journal of the American Society of Cytopathology},
year = {2023},
doi = {10.1016/j.jasc.2023.01.005}
}
EUVIMED